logo

Tonix Pharmaceuticals Holding Corp. (TNXP)



Trade TNXP now with
  Date
  Headline
7/16/2020 9:13:53 AM Tonix Enters Research Collaboration And Option Agreement With Columbia University
7/13/2020 7:15:15 AM Tonix Enters Research And Exclusive License Option Agreement With Kansas State University
7/7/2020 7:26:42 AM Tonix Intends To Purchase 40,000 Square Foot Facility In Massachusetts
6/29/2020 7:36:10 AM Tonix Pharma Announces Enrollment Of Phase 3 RELIEF Trial Of TNX-102 SL For Management Of Fibromyalgia
6/18/2020 7:07:30 AM Tonix Pharma Announces Expansion Of COVID-19 Vaccine Collaboration With Southern Research
6/1/2020 7:15:51 AM FDB To Provide Contract Manufacturing And Development Services To Support Tonix's TNX-1800
5/12/2020 7:40:52 AM Tonix Pharma Q1 Loss Available To Common Stockholders $9.0 Mln Or $0.37/Shr Vs Loss Of $6.2 Mln Or $12.76/Shr Last Year
4/24/2020 7:07:35 AM Tonix: 50% Of Total Number Of Participants Randomized In Phase 3 RELIEF Trial
2/28/2020 8:50:54 AM Tonix Pharmaceuticals Prices $16.01 Mln Common Stock Offering